Le Lézard
Classified in: Health, Science and technology
Subjects: NPT, CHI, TDS

Leading Voices in Evidence-aligned Reading Instruction to Converge at The Reading League Summit 2024 in San Diego


SYRACUSE, N.Y., April 23, 2024 /PRNewswire/ -- The Reading League, a national nonprofit organization leading the advancement of evidence-aligned reading instruction, is expecting nearly 1,000 attendees at its second annual Summit, "Finding Alignment: From Research to Practice" Saturday at the Town and Country Resort in San Diego.

Educators, researchers, and advocates will discuss the latest advancements in literacy instruction.

The event will bring together renowned experts, educators, researchers, and advocates to discuss the latest advancements in literacy instruction. Opening speakers include Dr. Maria Murray, CEO and President of The Reading League; Kari Kurto, National Science of Reading Project Director at The Reading League; Martha Hernandez, Executive Director of Californians Together; and neuroscientist Dr. Stanislas Dehaene, one of the most notable experts on learning and the brain, who will deliver the morning's virtual keynote address.

The full schedule and list of speakers can be found here.

"We are fortunate to bring together such a remarkable lineup of speakers and panelists who are at the forefront of evidence-aligned reading instruction, specifically for English learners and emergent bilingual students," Dr. Murray said. "Remarkably, the number of registered attendees has doubled this year, which affirms the value of the Summit."

The agenda for the Summit is designed to facilitate in-depth discussions and collaboration. Panels will cover a wide range of topics, including neuroscience and research, equitable assessment data for English learners and emergent bilinguals, connecting research to classroom practice, and developing sustainable evidence-aligned systems. Each panel will feature leading experts in their respective fields.

In addition to the informative sessions, attendees will have the opportunity to network, explore an expo featuring educational resources, and engage in table discussions to exchange ideas and best practices.

About The Reading League:
The Reading League is a nonprofit organization dedicated to advancing the awareness, understanding, and use of evidence-aligned reading instruction. Through professional development, advocacy, and community engagement, The Reading League aims to improve reading outcomes for all children. We believe that all children deserve to learn to read, and all teachers can learn to teach them. For more information, visit thereadingleague.org.

SOURCE The Reading League


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: